Document Detail


Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat.
MedLine Citation:
PMID:  1522509     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. We studied the effects of NG-nitro-L-arginine (NOLA), a potent inhibitor of the L-arginine-nitric oxide pathway, and L-arginine, the precursor of nitric oxide, on regional cerebral blood flow, electrocortical activity and ex vivo cerebrovascular reactivity in the cat. Flow was measured via radiolabelled microspheres, and vascular responses were studied by measuring isometric tension of isolated middle cerebral arterial rings. 2. NOLA (30 mg kg-1 bolus followed by 1 mg kg-1 min-1 infusion) caused an approximately 40 mmHg elevation in the mean arterial blood pressure, a regionally heterogenous increase of the regional cerebrovascular resistance and a decrease in the regional cerebral blood flow 15 and 40 min after the start of its administration. In contrast L-arginine (30 mg kg-1 bolus followed by 10 mg kg-1 min-1 infusion) did not alter blood pressure, cerebrovascular resistance nor regional cerebral blood flow 15 min after the start of its administration. The NOLA-induced changes in tissue flow were the most pronounced in the cerebellum, pituitary and medulla oblongata, whereas there was no decrease in the flow of the cortex and white matter. 3. NOLA caused characteristic changes in total fronto-occipital EEG power and in power spectra which were unlikely to have been due to cerebral ischaemia. In addition, the ex vivo reactivity of the middle cerebral arteries showed signs of impaired endothelial nitric oxide synthesis: there were enhanced noradrenaline-induced contractions and N-ethoxycarbonyl-3-morpholino-sydnonimine (SIN-1)-induced relaxations and markedly attenuated acetylcholine- and ATP-induced relaxations after NOLA treatment. 4. The present data indicate that resting cerebral blood flow and cerebrovascular resistance are regulated by nitric oxide derived from L-arginine in a regionally heterogenous way and that exogenous L-arginine availability is not a limiting factor in this nitric oxide generation. Possibly, both the vascular endothelium and the neurons contribute to this basal nitric oxide release.
Authors:
A G Kovách; C Szabó; Z Benyó; C Csáki; J H Greenberg; M Reivich
Related Documents :
16148609 - Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arte...
11587919 - Role of nitric oxide in the control of ocular blood flow.
8518329 - Circulatory effects caused by intra-arterial infusion of amp, adp and atp in the canine...
17158349 - Key role of the no-pathway and matrix metalloprotease-9 in high blood flow-induced remo...
1858919 - Microvascular recruitment in hamster striated muscle: role for conducted vasodilation.
2091239 - Arterial responses to compromised blood flow.
416759 - To pulse or not to pulse.
14512309 - In vitro and in vivo effects of tpa and pai-1 on blood vessel tone.
2395609 - Fetal hind limb oxygen consumption and blood flow during acute graded hypoxia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of physiology     Volume:  449     ISSN:  0022-3751     ISO Abbreviation:  J. Physiol. (Lond.)     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-10-13     Completed Date:  1992-10-13     Revised Date:  2010-09-07    
Medline Journal Info:
Nlm Unique ID:  0266262     Medline TA:  J Physiol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  183-96     Citation Subset:  IM    
Affiliation:
Cerebrovascular Research Center, University of Pennsylvania, Philadelphia 19104-6063.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Arginine / analogs & derivatives*,  pharmacology*
Blood Pressure / drug effects
Cats
Cerebral Arteries / physiology
Cerebrovascular Circulation / drug effects*
Male
Nitroarginine
Vascular Resistance / drug effects*
Grant Support
ID/Acronym/Agency:
NS 10939-18/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
2149-70-4/Nitroarginine; 74-79-3/Arginine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transmucosal electrical resistance in rabbit isolated gastric mucosa during exposure to acid.
Next Document:  Effects of proteins on the permeability of monolayers of cultured bovine arterial endothelium.